Viewing StudyNCT06457854



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06457854
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-13
First Post: 2024-05-23

Brief Title: Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With OlaparibAbiraterone
Sponsor: AstraZeneca
Organization: AstraZeneca

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-07-20
Start Date Type: ESTIMATED
Primary Completion Date: 2025-09-23
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-09-23
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-23
First Submit QC Date: June 11 2024
Study First Post Date: 2024-06-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-10
Last Update Post Date: 2024-06-13
Last Update Post Date Type: ACTUAL